NCT07474090 2026-03-16
STEPS-BC
Wake Forest University Health Sciences
Phase NA Not yet recruiting
Clinical Trials
13 trialsNCT05269381 2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2 Recruiting
NCT07078604 2026-03-12
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
University of Washington
Phase 2 Recruiting
NCT06315296 2026-03-03
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
Thomas Jefferson University
Phase NA Terminated
NCT06179303 2026-02-27
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
University of Washington
Phase 2 Recruiting
NCT03179904 2026-02-24
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
Mayo Clinic
Phase 2 Active not recruiting
NCT04521764 2026-01-08
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Mayo Clinic
Phase 1 Recruiting
NCT01714128 2021-10-25
FES-PET for Patients Treated on NCI Protocol 8762
Washington University School of Medicine
Phase NA Withdrawn
NCT01807754 2020-05-21
Simulated Screening Study for Breast Imaging
University of Michigan
Completed
NCT04328194 2020-03-31
Autotaxin (ATX) as a Marker for Breast Cancer
Assiut University
Phase NA Unknown
NCT00632541 2018-02-14
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
Hoosier Cancer Research Network
Phase 2 Terminated
NCT00420433 2016-02-19
Bone Response in Metastatic Breast Cancer Involving Bones
M.D. Anderson Cancer Center
Completed
NCT01081600 2013-05-14
AUY922
University Medical Center Groningen
Completed